Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lotze

Showing results (131-140 of 242) with videos related to

Pageof 25
Sort By:
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1996
Inhibition of nitric oxide synthesis does not improve interleukin-2-mediated antitumor effects in vivoG H Leder, M Oppenheim, M Rosenstein, et al.
JAMA|December 12, 1986
High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findingsM T Lotze, A E Chang, C A Seipp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytesH Stötter, E A Wiebke, S Tomita, et al.
Human Immunology|June 1, 1990
Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applicationsM T Lotze, M C Custer, E S Bolton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokinesC C Wilson, W C Olson, T Tuting, et al.
JAMA|November 14, 1980
Pulmonary shunting during leukoagglutinin-induced noncardiac pulmonary edemaM Dubois, M T Lotze, W J Diamond, et al.
Archives of Otolaryngology--Head & Neck Surgery|June 25, 1998
Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinomaS A Goldman, E Baker, R J Weyant, et al.
Radiology|April 1, 1992
Delayed reactions to contrast media after interleukin-2 immunotherapyP L Choyke, D L Miller, M T Lotze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphomaJ H Donohue, M Rosenstein, A E Chang, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1995
Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytesM J Maeurer, D M Martin, C Castelli, et al.
Pageof 25

Showing results (131-140 of 242) with videos related to

Sort By:
Pageof 25
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1996
Inhibition of nitric oxide synthesis does not improve interleukin-2-mediated antitumor effects in vivoG H Leder, M Oppenheim, M Rosenstein, et al.
JAMA|December 12, 1986
High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findingsM T Lotze, A E Chang, C A Seipp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytesH Stötter, E A Wiebke, S Tomita, et al.
Human Immunology|June 1, 1990
Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applicationsM T Lotze, M C Custer, E S Bolton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokinesC C Wilson, W C Olson, T Tuting, et al.
JAMA|November 14, 1980
Pulmonary shunting during leukoagglutinin-induced noncardiac pulmonary edemaM Dubois, M T Lotze, W J Diamond, et al.
Archives of Otolaryngology--Head & Neck Surgery|June 25, 1998
Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinomaS A Goldman, E Baker, R J Weyant, et al.
Radiology|April 1, 1992
Delayed reactions to contrast media after interleukin-2 immunotherapyP L Choyke, D L Miller, M T Lotze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphomaJ H Donohue, M Rosenstein, A E Chang, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1995
Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytesM J Maeurer, D M Martin, C Castelli, et al.
Pageof 25